Studies of recovery from a lingering and hard to treat problem like Cancer require long-term studies.
Three years or so to complete the follow-up work tracking those who recieved treatment and their outcomes is probably a minimum to see whether there is a significant advantage to recieveing the treatments over 'gold standard' treatments already in place.
My guess - there will be data released before 3 years IF a determination that there is an early, significant effect (or for that matter no significant early effect) of treatment with Multikine over controls. When exactly that would happen? Your guess is likely as good as any I might make.
If the early findings are favorable (sometime after this month, or perhaps by autumn 2012), then we might expect a shareprice increase as outside interest in the company rises. If one is a trader type (I, for the record don't trade in and out) that might be a good time to take profits, and wait for a sag in shareprice as we wait out longer-term positive (or negative) results.
I'll be watching with interest too when the preliminary results start to be made public.
News 
Market Data 
Discover 
